Further prospective studies are necessary, with a focus on the accurate reporting of benign lesions and inclusion of patients with an intermediate probability of HCC, which will allow accurate reporting of specificity and establish the true diagnostic accuracy of PSMA PET for HCC. Here, FOLH1 is linked to hepatocellular carcinoma.